Brind.

Align Technology reported weak Q2 performance and patient conversion in parts of Europe.

2 reports, 1 independent Updated Aug 13
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Align Technology reported weak Q2 performance and patient conversion in parts of Europe.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Align Technology CEO addressed weak Q2 performance and patient conversion in Europe.1 source
  2. Hogan cited reduced patient traffic and consumer reluctance regarding Align Technology's performance.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • StockStory5 Must-Read Analyst Questions From Align Technology’s Q2 Earnings Call Align Technology’s second quarter was marked by lower-than-expected revenue and profit, which led to a substantial negative mark
  • StockStoryALGN Q2 Deep Dive: Tariffs, Consumer Caution, and Restructuring Shape Outlook Dental technology company Align Technology (NASDAQ:ALGN) fell short of the market’s revenue expectations in Q2 CY2025, wi